START OFF WITH COURAGE

Coping with hypophosphatasia (HPP) can be difficult, but starting treatment shouldn’t have to be. The STRENSIQ® (asfotase alfa) starter kit is equipped with tools to help familiarize you with STRENSIQ.

Man talking with physician
Jump Btn

WHAT’S IN THE STARTER KIT?

STRENSIQ patient brochure
STRENSIQ patient brochure
Detailed information on how STRENSIQ works and what to expect while taking treatment.
Patient education event card
Patient education event card
Find out more about how to engage in educational programs for patients and caregivers.
Symptom tracker and log
Symptom tracker and log
Use this journal to help track symptoms and prepare for doctor’s visits.
Medical alert card
Medical alert card
Carry this wallet-sized card to help inform emergency room staff, doctors, or care providers of your condition.
OneSource brochure
OneSource™ brochure
An overview of services provided by your OneSource Case Manager.
US Prescribing Information
US Prescribing Information
Complete medical information about STRENSIQ.
Phone ringing icon

As you review these materials, remember that you can always talk with a OneSource Case Manager at 1.888.765.4747 or email OneSource@alexion.com.

Man picking up phone

HOW TO REQUEST A STARTER KIT

Once a doctor prescribes STRENSIQ, you can request a starter kit through OneSource as the patient or caregiver. A OneSource Case Manager will arrange the delivery of the starter kit.

OneSource® logo
Woman and boy in museum looking at exhibit
Woman and boy in museum looking at exhibit

WHAT WAS YOUR TREATMENT JOURNEY LIKE?

Hear others talk about starting and staying on STRENSIQ.

LOOKING FOR SUPPORT?

In the STRENSIQ starter kit, you’ll find helpful information about beginning treatment. Learn about more resources available to people living with HPP and their loved ones.

RESOURCES
× +
IMPORTANT SAFETY INFORMATION & INDICATION

STRENSIQ may cause serious side effects, including

  • Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
    • Difficulty breathing
    • Swelling of your eyes, lips, or tongue
    • Hives
    • Feeling faint
    • Nausea or vomiting
    • Dizziness
    • Itching of your lips, tongue, or throat
    • Choking sensation
  • Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
  • Calcium buildup in the eyes and kidneys can occur if you or your loved one have HPP. Your healthcare provider should check the eyes and kidneys while you or your loved one use STRENSIQ.
  • Decreased efficacy. Contact your healthcare provider if you or your loved one notice STRENSIQ is no longer working or experience worsening symptoms of HPP (e.g., increased respiratory support, increased difficulty walking, new fractures).

The most common side effects of STRENSIQ include local skin injection-site reactions (red skin patches, bruising, color change, pain, itching, thinning, swelling, pits, and bumps) and calcium buildup in your eyes and kidneys.

Strensiq may affect other lab test results, therefore it is important that you present your Medical Alert Card to your healthcare team so they are aware that you are being treated with an alkaline phosphatase (ALP) replacement therapy which may cause incorrect results on certain laboratory tests.

Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.

These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1‑800‑FDA‑1088.

INDICATION
What is STRENSIQ?
Strensiq is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).

Please see STRENSIQ full Prescribing Information, including Patient Information and Instructions for Use.
IMPORTANT SAFETY INFORMATION & INDICATION

STRENSIQ may cause serious side effects, including

  • Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
    • Difficulty breathing
    • Swelling of your eyes, lips, or tongue
    • Hives
    • Feeling faint
    • Nausea or vomiting
    • Dizziness
    • Itching of your lips, tongue, or throat
    • Choking sensation
  • Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
  • Calcium buildup in the eyes and kidneys can occur if you or your loved one have HPP. Your healthcare provider should check the eyes and kidneys while you or your loved one use STRENSIQ.
  • Decreased efficacy. Contact your healthcare provider if you or your loved one notice STRENSIQ is no longer working or experience worsening symptoms of HPP (e.g., increased respiratory support, increased difficulty walking, new fractures).

The most common side effects of STRENSIQ include local skin injection-site reactions (red skin patches, bruising, color change, pain, itching, thinning, swelling, pits, and bumps) and calcium buildup in your eyes and kidneys.

Strensiq may affect other lab test results, therefore it is important that you present your Medical Alert Card to your healthcare team so they are aware that you are being treated with an alkaline phosphatase (ALP) replacement therapy which may cause incorrect results on certain laboratory tests.

Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.

These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1‑800‑FDA‑1088.

INDICATION
What is STRENSIQ?
Strensiq is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).

Please see STRENSIQ full Prescribing Information, including Patient Information and Instructions for Use.